UnitedHealth Group (NYSE:UNH) Stock Acquired Rep. Marjorie Taylor Greene

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on May 19th, the Representative disclosed that they had bought between $15,001 and $50,000 in UnitedHealth Group stock on May 14th.

Representative Marjorie Taylor Greene also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 5/16/2025.
• Purchased $1,001 – $15,000 in shares of Eli Lilly and Company (NYSE:LLY) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Impinj (NASDAQ:PI) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Corning (NYSE:GLW) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Cardinal Health (NYSE:CAH) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Chevron (NYSE:CVX) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Blackstone (NYSE:BX) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 5/14/2025.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $295.37 on Friday. The firm has a fifty day moving average price of $452.40 and a two-hundred day moving average price of $505.07. The company has a market cap of $267.94 billion, a PE ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the business posted $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.84%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

Institutional Investors Weigh In On UnitedHealth Group

Institutional investors have recently modified their holdings of the business. Mattson Financial Services LLC boosted its stake in UnitedHealth Group by 15.2% during the 1st quarter. Mattson Financial Services LLC now owns 10,403 shares of the healthcare conglomerate’s stock worth $5,449,000 after acquiring an additional 1,371 shares during the last quarter. WBI Investments LLC bought a new position in UnitedHealth Group during the 1st quarter worth approximately $316,000. Acadian Asset Management LLC boosted its stake in UnitedHealth Group by 150.9% during the 1st quarter. Acadian Asset Management LLC now owns 148,918 shares of the healthcare conglomerate’s stock worth $77,984,000 after acquiring an additional 89,560 shares during the last quarter. Acorns Advisers LLC boosted its stake in UnitedHealth Group by 16.9% during the 1st quarter. Acorns Advisers LLC now owns 547 shares of the healthcare conglomerate’s stock worth $286,000 after acquiring an additional 79 shares during the last quarter. Finally, Fortis Capital Advisors LLC boosted its holdings in shares of UnitedHealth Group by 59.1% in the first quarter. Fortis Capital Advisors LLC now owns 619 shares of the healthcare conglomerate’s stock valued at $324,000 after buying an additional 230 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on UNH shares. HSBC reaffirmed a “reduce” rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday. Wolfe Research dropped their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday. Oppenheimer dropped their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Finally, Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $441.87.

Insider Activity

In other UnitedHealth Group news, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO John F. Rex bought 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares of the company’s stock, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.33% of the stock is currently owned by company insiders.

About Representative Greene

Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia’s 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 14th Congressional District. She declared candidacy for the 2026 election.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.